Pedro Berraondo

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 55

Top Topics

Silver Nanoparticles

Immune Response

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Iñaki Eguren, Eva Fernández de Piérola, Gracián Camps, Paula Martín-Muñoz, María Campos, Doina Cuculescu, Inmaculada Aguilera-Buenosvinos, Inmaculada Rodríguez López, Rafael Salido-Vallejo, Raluca Alexandru, Carlos E De Andrea, Laura Álvarez-Gigli, Pedro Berraondo, Ignacio Melero Bermejo, Miguel F Sanmamed
MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers. Journal for immunotherapy of cancer 12 (9) (2024)
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Marina Barcena-Varela, Pedro Berraondo
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma. Gut 73 (6) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Alvaro Teijeira, Saray Garasa, María Carmen Ochoa, Sandra Sanchez-Gregorio, Gabriel Gomis, Carlos Luri-Rey, Rafael Martinez-Monge, Beatrice Pinci, Karmele Valencia, Belen Palencia, Benigno Barbes, Elixabet Bolaños, Arantza Azpilikueta, Marina Garcia-Cardosa, Javier Burguete, Iñaki Eguren, Eneko Garate-Soraluze, Pedro Berraondo, Jose-Luis Perez-Gracia, Carlos E De Andrea, Maria E Rodríguez-Ruiz, Ignacio Melero Bermejo
Low-dose ionizing γ-radiation elicits the extrusion of neutrophil extracellular traps. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Marina Barcena-Varela, Pedro Berraondo
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma. Gut 73 (6) (2024)
Marina Barcena-Varela, Pedro Berraondo
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma. Gut (2024)
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Javier Glez-Vaz, Arantza Azpilikueta, María Carmen Ochoa, Irene Olivera, Gabriel Gomis, Assunta Cirella, Carlos Luri-Rey, Maite Alvarez, Jose-Luis Perez-Gracia, Sergio Ciordia, Iñaki Eguren, Raluca Alexandru, Pedro Berraondo, Carlos E De Andrea, Alvaro Teijeira, Fernando Corrales, Juan M Zapata, Ignacio Melero Bermejo
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects. Science advances 9 (33) (2023)
Irene Olivera, Carlos Luri-Rey, Alvaro Teijeira, Iñaki Eguren, Gabriel Gomis, Belen Palencia, Pedro Berraondo, Ignacio Melero Bermejo
Facts and hopes on neutralization of protumor inflammatory mediators in cancer immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Carlos Luri-Rey, Iñaki Eguren, Ignacio Matos, Pedro Berraondo, Ignacio Melero Bermejo
Druggable targets in cytokine release syndromes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Maritza Roxana Garcia-Garcia, Noelia Casares, Luz Andrea Martínez-Pérez, Efren Juarez Curiel, Andres Alberto de Jesus Hernandez, Nina Bogdanchikova, Diana Garibo, Ana G Rodríguez-Hernández, Alexey N Pestryakov, Sandra Castro-Gamboa, Luis Felipe Arias Ruiz, Olivia Torres Bugarin, Pedro Berraondo
Silver nanoparticles induce a non-immunogenic tumor cell death. Journal of immunotoxicology 20 (1) (2023)
Maritza Roxana Garcia-Garcia, Noelia Casares, Luz Andrea Martínez-Pérez, Efren Juarez Curiel, Andres Alberto de Jesus Hernandez, Nina Bogdanchikova, Diana Garibo, Ana G Rodríguez-Hernández, Alexey N Pestryakov, Sandra Castro-Gamboa, Luis Felipe Arias Ruiz, Olivia Torres Bugarin, Pedro Berraondo
Silver nanoparticles induce a non-immunogenic tumor cell death. Journal of immunotoxicology 20 (1) (2023)
Ángela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, Jose Gonzalez-Gomariz, Celia Gomar, Joan Salvador Russo-Cabrera, Irene Olivera, Assunta Cirella, Myriam Fernandez-Sendin, Maite Alvarez, Alvaro Teijeira, Cigdem Atay, José Medina-Echeverz, Maria Hinterberger, Hubertus Hochrein, Ignacio Melero Bermejo, Pedro Berraondo, Fernando Aranda
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis. Journal for immunotherapy of cancer 11 (11) (2023)
Ignacio Melero, Alvaro Teijeira, Fernando Aranda, Pedro Berraondo
Firefighters for the Wrong Type of Inflammation in Tumors. Cancer discovery 11 (10) (2022)
Miguel F Sanmamed, Pedro Berraondo, Maria E Rodriguez-Ruiz, Ignacio Melero Bermejo
Charting roadmaps towards novel and safe synergistic immunotherapy combinations. Nature cancer 3 (6) (2022)
Ángela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, Assunta Cirella, Myriam Fernandez-Sendin, Celia Gomar, Joan Salvador Russo-Cabrera, Inmaculada Rodríguez, José González-Gomariz, Maite Alvarez, Álvaro Teijeira, José Medina-Echeverz, Maria Hinterberger, Hubertus Hochrein, Ignacio Melero, Pedro Berraondo, Fernando Aranda
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis. Oncoimmunology 11 (1) (2022)
Alvaro Teijeira, Saray Garasa, Carlos Luri-Rey, Carlos E De Andrea, Maria Gato-Cañas, Carmen Molina, Tsuneyasu Kaisho, Assunta Cirella, Arantza Azpilikueta, Steffanie K Wculek, Josune Egea, Irene Olivera, Inmaculada Rodriguez, Ana Rouzaut, Vladislav V Verkhusha, Karmele Valencia, David Sancho, Pedro Berraondo, Ignacio Melero Bermejo
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy. Cancer research 82 (23) (2022)
Karol Marcela Córdoba, Irantzu Serrano-Mendioroz, Daniel Jericó, María Merino, Lei Jiang, Ana Sampedro, Manuel Alegre, Fernando Corrales, María J Garrido, Paolo G V Martini, José Luis Lanciego, Jesús Prieto, Pedro Berraondo, Antonio Fontanellas
Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria. Science translational medicine 14 (627) (2022)
Fernando Aranda, Iñaki Eguren, Ángela Bella, Pedro Berraondo, Ignacio Melero Bermejo
Revisiting Intracavitary Immunotherapy of Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Irene Olivera, Vicente Martín, Elixabet Bolaños, Inmaculada Rodriguez, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Saray Garasa, Itziar Migueliz, Iñaki Eguren, Miguel F Sanmamed, Javier Glez-Vaz, Arantza Azpilikueta, Maite Alvarez, María Carmen Ochoa, Beatrice Malacrida, David J Propper, Carlos E De Andrea, Pedro Berraondo, Frances R Balkwill, Alvaro Teijeira, Ignacio Melero Bermejo
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β. Cancer discovery 12 (9) (2022)
Shirley Tenesaca, Marcos Vasquez, Maite Alvarez, Itziar Otano, Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Nuria Ardaiz, Celia Gomar, Angela Bella, Fernando Aranda, José Medina-Echeverz, Ignacio Melero Bermejo, Pedro Berraondo
Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors. Journal for immunotherapy of cancer 9 (7) (2022)
Assunta Cirella, Elixabet Bolaños, Claudia Augusta Di Trani, Carlos E De Andrea, Sandra Sanchez-Gregorio, Iñaki Etxeberría, Jose Gonzalez-Gomariz, Irene Olivera, Davide Brocco, Javier Glez-Vaz, Carlos Luri-Rey, Arantza Azpilikueta, Inmaculada Rodriguez, Myriam Fernandez-Sendin, Josune Egea, Iñaki Eguren, Miguel F Sanmamed, Belen Palencia, Alvaro Teijeira, Pedro Berraondo, Ignacio Melero Bermejo
Intratumoral gene transfer of mRNAs encoding interleukin-12 in combination with decoy-resistant interleukin-18 improves local and systemic antitumor immunity. Cancer immunology research (2022)
Daniel Jericó, Karol Marcela Córdoba, Ana Sampedro, Lei Jiang, Gilles Joucla, Charlotte Cabanne, José Luis Lanciego, Paolo G V Martini, Pedro Berraondo, Matias A Avila, Antonio Fontanellas
Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment. Life (Basel, Switzerland) 12 (11) (2022)
Mariona Cabo, Sara Santana-Hernández, Marcel Costa-García, Anna Rea, Roberto Lozano-Rodríguez, Michelle Ataya, Francesc Balaguer, Manel Juan, María Carmen Ochoa, Silvia Menéndez, Laura Comerma, Ana Rovira, Pedro Berraondo, Joan Albanell, Ignacio Melero, Miguel López-Botet, Aura Muntasell
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function. Cancer immunology research 9 (12) (2021)
Aymara Sancho-Araiz, Sara Zalba, María J Garrido, Pedro Berraondo, Brian Topp, Dinesh de Alwis, Zinnia P Parra-Guillen, Victor Mangas Sanjuan, Iñaki F Trocóniz
Semi-Mechanistic Model for the Antitumor Response of a Combination Cocktail of Immuno-Modulators in Non-Inflamed (Cold) Tumors. Cancers 13 (20) (2021)
Ángela Bella, Claudia Augusta Di Trani, Myriam Fernandez-Sendin, Leire Arrizabalaga, Assunta Cirella, Alvaro Teijeira, José Medina-Echeverz, Ignacio Melero Bermejo, Pedro Berraondo, Fernando Aranda
Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications. Cancers 13 (5) (2021)
Maite Alvarez, Carmen Molina, Carlos E De Andrea, Myriam Fernandez-Sendin, Maria Villalba, Jose Gonzalez-Gomariz, Maria Carmen Ochoa, Alvaro Teijeira, Javier Glez-Vaz, Fernando Aranda, Miguel F Sanmamed, Maria E Rodriguez-Ruiz, Xinyi Fan, Wen H Shen, Pedro Berraondo, Marisol Quintero, Ignacio Melero Bermejo
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy. Journal for immunotherapy of cancer 9 (11) (2021)
Maria Hinterberger, Raphael Giessel, Giovanna Fiore, Fabienne Graebnitz, Barbara Bathke, Sonia Wennier, Paul Chaplin, Ignacio Melero Bermejo, Mark Suter, Henning Lauterbach, Pedro Berraondo, Hubertus Hochrein, José Medina-Echeverz
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory. Journal for immunotherapy of cancer 9 (2) (2021)
Alvaro Teijeira, Saray Garasa, Maria Del Carmen Ochoa, Assunta Cirella, Irene Olivera, Javier Glez-Vaz, Maria Pilar Andueza, Itziar Migueliz, Maite Alvarez, Maria Esperanza Rodríguez-Ruiz, Ana Rouzaut, Pedro Berraondo, Miguel F Sanmamed, Jose L Perez Gracia, Ignacio Melero Bermejo
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils. European journal of immunology 51 (9) (2021)
Isabel Solares, Laura Izquierdo-Sanchez, Montserrat Morales-Conejo, Daniel Jericó, Francisco Javier Castelbón, Karol Marcela Córdoba, Ana Sampedro, Carlos Lumbreras, María Jesús Moreno-Aliaga, Rafael Enríquez de Salamanca, Pedro Berraondo, Antonio Fontanellas
High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach. Biomedicines 9 (3) (2021)
Itziar Otano, Arantza Azpilikueta, Javier Glez-Vaz, Maite Alvarez, José Medina-Echeverz, Ivan Cortés-Domínguez, Carlos Ortiz de Solórzano, Peter Ellmark, Sara Fritzell, Gabriela Hernandez-Hoyos, Michelle Hase Nelson, María Carmen Ochoa, Elixabet Bolaños, Doina Cuculescu, Patricia Jaúregui, Sandra Sanchez-Gregorio, Iñaki Etxeberría, María E Rodriguez-Ruiz, Miguel F Sanmamed, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero Bermejo
CD137 (4-1BB) costimulation of CD8 + T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation. Nature communications 12 (1) (2021)
Claudia Augusta Di Trani, Myriam Fernandez-Sendin, Assunta Cirella, Aina Segués, Irene Olivera, Elixabet Bolaños, Ignacio Melero, Pedro Berraondo
Advances in mRNA-based drug discovery in cancer immunotherapy. Expert opinion on drug discovery (2021)
Xabier Mielgo-Rubio, Virginia Calvo, Javier Luna, Jordi Remon, Margarita Martín, Pedro Berraondo, José Ramón Jarabo, Oliver Higuera, Esther Conde, Javier De Castro Carpeño, Mariano Provencio, Florentino Hernando Trancho, Fernando López-Ríos, Felipe Couñago
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers. Cancers 12 (11) (2020)
Luna Minute, Alvaro Teijeira, Alfonso R Sanchez-Paulete, Maria C Ochoa, Maite Alvarez, Itziar Otano, Iñaki Etxeberrria, Elixabet Bolaños, Arantza Azpilikueta, Saray Garasa, Noelia Casares, Jose Luis Perez Gracia, Maria E Rodriguez-Ruiz, Pedro Berraondo, Ignacio Melero Bermejo
Cellular cytotoxicity is a form of immunogenic cell death. Journal for immunotherapy of cancer 8 (1) (2020)
Assunta Cirella, Pedro Berraondo, Claudia Augusta Di Trani, Ignacio Melero
Interleukin-12 Message in a Bottle. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Alvaro Teijeira, Saray Garasa, María Carmen Ochoa, María Villalba-Esparza, Irene Olivera, Assunta Cirella, Iñaki Eguren, Pedro Berraondo, Kurt A Schalper, Carlos E de Andrea, Miguel F Sanmamed, Ignacio Melero
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2020)
Shirley Tenesaca, Marcos Vasquez, Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Nuria Ardaiz, Celia Gomar, Doina Cuculescu, Maite Alvarez, Itziar Otano, Ignacio Melero, Pedro Berraondo
Scavenger Receptor Class B Type I is Required for 25-Hydroxycholecalciferol Cellular Uptake and Signaling in Myeloid Cells. Molecular nutrition & food research 64 (15) (2020)
María E Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, Tania Labiano, Benigno Barbes, Iñaki Etxeberría, Mariano Ponz-Sarvisé, Arantza Azpilikueta, Elixabet Bolaños, Miguel F Sanmamed, Pedro Berraondo, Felipe A Calvo, Mary Helen Barcelos-Hoff, Jose L Perez-Gracia, Ignacio Melero
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies. Molecular cancer therapeutics 18 (3) (2019)
Iñaki Etxeberría, Alvaro Teijeira, Luis M Montuenga, Pedro Berraondo, Ignacio Melero
Epistatic Oncogenic Interactions Determine Cancer Susceptibility to Immunotherapy. Cancer discovery 8 (7) (2019)
Pedro Berraondo, María Carmen Ochoa, Irene Olivera, Ignacio Melero
Immune Desertic Landscapes in Hepatocellular Carcinoma Shaped by β-Catenin Activation. Cancer discovery 9 (8) (2019)
Maria C Ochoa, Elisabeth Perez-Ruiz, Luna Minute, Carmen Oñate, Guiomar Perez, Inmaculada Rodriguez, Aintzane Zabaleta, Diego Alignani, Myriam Fernandez-Sendin, Ascension Lopez, Aura Muntasell, Miguel F Sanmamed, Bruno Paiva, Miguel Lopez-Botet, Pedro Berraondo, Ignacio Melero
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells. Oncoimmunology 8 (7) (2019)
Kurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, Alvaro López-Janeiro, Angelo Porciuncula, Miguel A Idoate, Susana Inogés, Carlos de Andrea, Ascensión López-Diaz de Cerio, Sonia Tejada, Pedro Berraondo, Franz Villarroel-Espindola, Jungmin Choi, Alfonso Gúrpide, Miriam Giraldez, Iosune Goicoechea, Jaime Gállego Pérez-Larraya, Miguel F Sanmamed, Jose-Luis Perez-Gracia, Ignacio Melero Bermejo
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. Nature medicine 25 (3) (2019)
Marcos Vasquez, Marta Consuegra-Fernández, Fernando Aranda, Aitor Jimenez, Shirley Tenesaca, Myriam Fernandez-Sendin, Celia Gomar, Nuria Ardaiz, Claudia Augusta Di Trani, Noelia Casares, Juan Jose Lasarte, Francisco Lozano, Pedro Berraondo
Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α. Journal of immunology (Baltimore, Md. : 1950) 203 (3) (2019)
Alfonso R Sánchez-Paulete, Alvaro Teijeira, José I Quetglas, María E Rodríguez-Ruiz, Álvaro Sánchez-Arráez, Sara Labiano, Iñaki Etxeberría, Arantza Azpilikueta, Elixabet Bolaños, María Cristina Ballesteros-Briones, Noelia Casares, Sergio A Quezada, Pedro Berraondo, David Sancho, Cristian Smerdou, Ignacio Melero
Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming. Cancer research 78 (23) (2018)
Pedro Berraondo, Iñaki Etxeberria, Mariano Ponz-Sarvise, Ignacio Melero
Revisiting Interleukin-12 as a Cancer Immunotherapy Agent. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (12) (2018)
Lei Jiang, Pedro Berraondo, Daniel Jericó, Lin T Guey, Ana Sampedro, Andrea Frassetto, Kerry E Benenato, Kristine Burke, Eva Santamaría, Manuel Alegre, Álvaro Pejenaute, Mayur Kalariya, William Butcher, Ji-Sun Park, Xuling Zhu, Staci Sabnis, E Sathyajith Kumarasinghe, Timothy Salerno, Matthew Kenney, Christine M Lukacs, Matías A Ávila, Paolo G V Martini, Antonio Fontanellas
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria. Nature medicine 24 (12) (2018)
Pedro Berraondo, Maria Angela Aznar, Elisabeth Perez-Ruiz, Maria Esperanza Rodriguez-Ruiz, Eduardo Castañon, Jose-Luis Perez-Gracia, Ignacio Melero Bermejo
International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain. Cancer immunology, immunotherapy : CII 67 (11) (2018)